PD-L1 on the Edge: Cut-offs, Cognitive Bias & the Case for AI in Lung Cancer Pathology
PD-L1 TPS is simple in theory—but far more complex in practice. When eligibility for life-changing immunotherapy hinges on a 1% or 50% score, even a 5% margin of error can shift a patient’s path entirely.
